Nivolumab Promising for Treatment of Advanced Cutaneous SCC

Robust antitumor activity and good tolerability observed in phase 2 study of nivolumab for first - line treatment of advanced cutaneous squamous cell carcinoma
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Dermatology, Oncology, Pharmacy, Journal, Source Type: news